SNA vs XERS · P/E 17, rev $1.33B vs rev $175.2M
Snap-On Inc (SNA) versus Xeris Pharmaceuticals Inc (XERS) — a side-by-side from cached financials, not a winner call.
Snap-On Inc (SNA) is a tools & accessories company listed on US.
Xeris Pharmaceuticals Inc (XERS) is a biotechnology company listed on US.
Latest reported SNA revenue for 2026-07-04 was $1.33B. Net income was $260.6M. Revenue was up 2.0% from 2026-04-04 to 2026-07-04. SNA currently screens at market cap $16.82B and trailing P/E 16.8.
Latest reported XERS revenue for 2026-06-30 was $175.2M. Net income was -$28.9M. XERS currently screens at market cap $760.7M.
SNA currently screens at market cap $16.82B and trailing P/E 16.8. XERS currently screens at market cap $760.7M.
Not investment advice. Open the SNA and XERS stock pages for the full models.
Not investment advice.